© 2023 MergersCorp M&A International. is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.
This website is operated by MergersUS Inc.a US Corporation with registered office at 40th Wall Street, Suite #2725, New York, New York 10005, United States of America.
This Pharmaceutical Manufacturing Company was founded around 40-Year-Old in Amman, Jordan. It holds the regional benchmark in innovation with more than 70 patents.
As direct result of this innovation, operations were diversified outside the traditional generic pharmaceutical industry by spinning out mature technology platforms into subsidiaries with independent management and resources.
1. Core branded generic pharmaceutical business.
2. Natural products through the subsidiary.
3. Biotech diagnostics through the subsidiary.
4. Novel excipients and drug delivery systems through the subsidiary.
Products cover a wide range of therapeutic categories including the Cardiovascular, Gastrointestinal, Central Nervous System, Anti- Infective, Endocrine, Musculoskeletal, Respiratory, Obstetric, Gynecology & Urinary Tract, and Immune Systems.
It offers more than 200 pharmaceutical products that cover the needs of consumers and healthcare professionals. These products include tablets, capsules, suppositories, syrups and suspensions, which are manufactured in accordance with Good Manufacturing Practices (GMP). The company has a competitive advantage that makes it one of the leading pharmaceutical companies, as its products are of high “Quality”.
It is renowned as the one of the best company in the Middle East specializing in the development and production of plant and herbal medical products from standardized medicinal plant extracts, offering more than 50 natural and herbal innovative products with business operations in more than 20 countries worldwide.
It is a developer and producer of proprietary biotechnology healthcare products that specializes in the production.
© 2023 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.
This website is operated by MergersUS Inc.a US Corporation with registered office at 40th Wall Street, Suite #2725, New York, New York 10005, United States of America.
This website is operated by MergersUS Inc a US Corporation with registered office at
Error: Contact form not found.
Error: Contact form not found.
Error: Contact form not found.
Error: Contact form not found.
Description
This Pharmaceutical Manufacturing Company was founded around 40-Year-Old in Amman, Jordan. It holds the regional benchmark in innovation with more than 70 patents.
As direct result of this innovation, operations were diversified outside the traditional generic pharmaceutical industry by spinning out mature technology platforms into subsidiaries with independent management and resources.
Verticals
1. Core branded generic pharmaceutical business.
2. Natural products through the subsidiary.
3. Biotech diagnostics through the subsidiary.
4. Novel excipients and drug delivery systems through the subsidiary.
Products
Products cover a wide range of therapeutic categories including the Cardiovascular, Gastrointestinal, Central Nervous System, Anti- Infective, Endocrine, Musculoskeletal, Respiratory, Obstetric, Gynecology & Urinary Tract, and Immune Systems.
Pharmaceutical Business
It offers more than 200 pharmaceutical products that cover the needs of consumers and healthcare professionals. These products include tablets, capsules, suppositories, syrups and suspensions, which are manufactured in accordance with Good Manufacturing Practices (GMP). The company has a competitive advantage that makes it one of the leading pharmaceutical companies, as its products are of high “Quality”.
Natural Products
It is renowned as the one of the best company in the Middle East specializing in the development and production of plant and herbal medical products from standardized medicinal plant extracts, offering more than 50 natural and herbal innovative products with business operations in more than 20 countries worldwide.
Biotechnology
It is a developer and producer of proprietary biotechnology healthcare products that specializes in the production.
Basic Details
Target Price:
$45,000,000
Gross Revenue
$37,000,000
EBITDA
$6,279,944
Business ID:
L#20230509
Country
Jordan
Detail
Similar Businesses
Published on August 21, 2023 at 11:59 am. Updated on December 2, 2023 at 1:44 pm
40 Year Old Pharmaceutical Manufacturing Business
$40,000,000
Manufacturing, Pharma
40 Year Old Rx-pharma Manufacturing Business
$12,000,000
Manufacturing, Pharma
Ethical Pharmaceutical Manufacturing Company
$10,000,000
Manufacturing, Pharma
20-Year Old Pharmaceutical South American Brand
$11,500,000
Manufacturing, Pharma
Continued Medical Education & Strategic Consulting Organisation
$4,500,000
Medical Businesses, Pharma
PREVIOUS PROPERTY
American Financial Service Business
NEXT PROPERTY
Finish Professional Football Club